ATE209029T1 - Liposomen, die materialien in partikelform enthalten - Google Patents

Liposomen, die materialien in partikelform enthalten

Info

Publication number
ATE209029T1
ATE209029T1 AT94928490T AT94928490T ATE209029T1 AT E209029 T1 ATE209029 T1 AT E209029T1 AT 94928490 T AT94928490 T AT 94928490T AT 94928490 T AT94928490 T AT 94928490T AT E209029 T1 ATE209029 T1 AT E209029T1
Authority
AT
Austria
Prior art keywords
liposomes
water insoluble
particulate
mum
materials
Prior art date
Application number
AT94928490T
Other languages
English (en)
Inventor
Gregory Gregoriadis
Sophia George Antimisiaris
Ihsan Gursel
Original Assignee
Secr Defence Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence Brit filed Critical Secr Defence Brit
Application granted granted Critical
Publication of ATE209029T1 publication Critical patent/ATE209029T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/918—Immunological

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
AT94928490T 1993-10-07 1994-10-07 Liposomen, die materialien in partikelform enthalten ATE209029T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939320668A GB9320668D0 (en) 1993-10-07 1993-10-07 Liposomes containing particulare materials
PCT/GB1994/002191 WO1995009610A1 (en) 1993-10-07 1994-10-07 Liposomes containing particulate materials

Publications (1)

Publication Number Publication Date
ATE209029T1 true ATE209029T1 (de) 2001-12-15

Family

ID=10743157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94928490T ATE209029T1 (de) 1993-10-07 1994-10-07 Liposomen, die materialien in partikelform enthalten

Country Status (15)

Country Link
US (2) US6322809B1 (de)
EP (1) EP0722317B1 (de)
JP (1) JPH09503225A (de)
KR (1) KR100357804B1 (de)
CN (1) CN1108789C (de)
AT (1) ATE209029T1 (de)
AU (1) AU687893B2 (de)
BR (1) BR9407769A (de)
DE (1) DE69429186T2 (de)
DK (1) DK0722317T3 (de)
ES (1) ES2164714T3 (de)
GB (2) GB9320668D0 (de)
NZ (1) NZ274006A (de)
RU (1) RU2145212C1 (de)
WO (1) WO1995009610A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289938B1 (it) * 1997-02-20 1998-10-19 Angelini Ricerche Spa Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e
ES2343767T3 (es) * 1997-09-18 2010-08-09 Pacira Pharmaceuticals, Inc. Composiciones anestesicas liposomicas de liberacion sostenida.
JP4575592B2 (ja) 1997-11-14 2010-11-04 パシラ ファーマシューティカルズ インコーポレーテッド 多小胞リポソームの製造
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
FR2802422B1 (fr) * 1999-12-21 2002-08-09 Capsulis Structures mixtes resultant de l'incorporation d'une macromolecule biologique, en particulier d'adn, dans une phase structuree d'amphiphiles et vesicules obtenues a partir de ces structures
ATE341310T1 (de) * 2000-02-04 2006-10-15 Lipoxen Technologies Ltd Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
RU2191583C1 (ru) * 2001-03-28 2002-10-27 Лескова Галина Федоровна Способ коррекции геморрагического шока
US20030096000A1 (en) * 2001-05-31 2003-05-22 Solis Rosa Maria Encapsulation of nanosuspensions in liposomes and microspheres
US20040005352A1 (en) * 2002-04-16 2004-01-08 Lopez Gabriel P. Biologically functionalized porous microspheres
RU2217129C1 (ru) * 2002-10-28 2003-11-27 Государственный научно-исследовательский институт особо чистых биопрепаратов Способ получения липосомальных препаратов
SE0300795D0 (sv) 2003-03-24 2003-03-24 Isconova Ab Composition comprising iscom particles and live micro-organisms
US20060222694A1 (en) * 2003-06-27 2006-10-05 Oh Choon K Stabilized topotecan liposomal composition and methods
EP3015101B1 (de) 2005-10-03 2019-08-21 PINSKY, Mark A. Non-phospholipid liposomen enthaltend hyaluronsäure
FR2900576B1 (fr) * 2006-05-03 2008-09-19 Centre Nat Rech Scient Procede de concentration extemporanee et reversible de liposomes.
KR101333279B1 (ko) * 2006-10-06 2013-11-27 에스씨아이엘 테크놀로지 게엠베하 약학적 응용을 위한 건조된 재구성 소포 형성
US9456983B1 (en) 2006-12-08 2016-10-04 Advanced Cardiovascular Systems, Inc. Therapeutic composition with enhanced vessel targeting
US8372427B2 (en) 2007-03-05 2013-02-12 Abbott Cardiovascular Systems Inc. Therapeutic composition with enhanced endothelium targeting
US9044385B2 (en) * 2007-05-16 2015-06-02 Abbott Cardiovascular Systems Inc. Therapeutic compositions for targeted vessel delivery
US20090047318A1 (en) 2007-08-16 2009-02-19 Abbott Cardiovascular Systems Inc. Nanoparticle-coated medical devices and formulations for treating vascular disease
US8709472B1 (en) 2007-11-13 2014-04-29 Abbott Cardiovascular Systems Inc. Bioactive agent-loaded heart-targeting nanoparticles
ES2710498T3 (es) 2007-12-26 2019-04-25 Mark A Pinsky Formulaciones de colágeno para la mejora del cuidado de la piel
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions
WO2011123525A1 (en) * 2010-04-01 2011-10-06 The Regents Of The University Of California Forming an artificial cell with controlled membrane composition, asymmetry and contents
WO2011148207A1 (en) * 2010-05-28 2011-12-01 Diagon Kft. Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents
CN102240531B (zh) * 2011-03-21 2013-07-10 徐涵 一种植物细胞微球及其应用
EP2682106A1 (de) * 2012-07-03 2014-01-08 Phares Pharmaceutical Research N.V. Verfahren zum Auflösen biologisch aktiver Verbindungen
CA2943190A1 (en) * 2014-03-25 2015-10-01 The Government Of The United States Of America As Represented By The Secretary Of The Army Non-toxic adjuvant formulation comprising a monophosphoryl lipid a (mpla)-containing liposome composition and a saponin
RU2589822C2 (ru) * 2014-12-02 2016-07-10 Федеральное государственное бюджетное учреждение науки Институт ядерной физики им. Г.И. Будкера Сибирского отделения РАН (ИЯФ СО РАН) Способ доставки борсодержащих препаратов для бор-нейтронозахватной терапии
JP6316182B2 (ja) 2014-12-19 2018-04-25 富士フイルム株式会社 リポソームの製造方法及びリポソーム製造装置
US20170049701A1 (en) * 2015-08-05 2017-02-23 Steven M. Kushner Clustoidal multilamellar soy lecithin phospholipid structures for transdermal, transmucosal, or oral delivery, improved intestinal absorption, and improved bioavailability of nutrients
KR101687735B1 (ko) * 2015-09-18 2016-12-19 서울대학교 산학협력단 신규의 동결건조보조제 및 새로운 인지질 용해용 혼합용매를 이용한 리포좀 동결분체의 제조방법
EP3371349A4 (de) 2015-11-02 2018-09-12 Bioatla, LLC Bedingt aktive polypeptide
CN105483076B (zh) * 2015-12-23 2019-01-25 中国科学院生物物理研究所 一种脂肪体的制备方法及其应用
CN109983013A (zh) 2016-11-18 2019-07-05 帕西拉制药有限公司 美洛昔康锌复合物微粒多囊脂质体制剂及其制备方法
EP3415140A1 (de) * 2017-06-16 2018-12-19 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur herstellung einer funktionellen synthetischen zelle in form eines gigantischen unilamellaren vesikels
US10849924B2 (en) 2017-09-26 2020-12-01 New York Medical College Compositions and methods for restoring endothelial glycocalyx
JP7157999B2 (ja) * 2018-05-07 2022-10-21 国立研究開発法人産業技術総合研究所 微生物を封入したベシクルを用いた微生物の培養方法
MX2023003104A (es) 2020-09-16 2023-06-22 Aviceda Therapeutics Inc Agentes terapéuticos decorados con ligando de ácido siálico.
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
GB2627096A (en) 2021-10-14 2024-08-14 Pacira Pharmaceuticals Inc Bupivacaine multivesicular liposome formulations and uses thereof
JP2025502829A (ja) 2021-12-31 2025-01-28 アビセーダ セラピューティクス，インコーポレイテッド 糖模倣リガンド
CN121285391A (zh) 2023-04-14 2026-01-06 艾维达治疗公司 聚唾液酸-聚合物缀合物和纳米颗粒
US12251468B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12246092B1 (en) 2024-05-20 2025-03-11 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201767A (en) * 1978-11-08 1980-05-06 Merck & Co., Inc. Viral liposome particle
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
US4532089A (en) 1984-01-14 1985-07-30 Northwestern University Method of preparing giant size liposomes
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
EP0172007B1 (de) * 1984-08-10 1991-05-22 Syntex (U.S.A.) Inc. Stabile Liposome mit wasserlöslichen Arzneimitteln
JPS6150912A (ja) 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
US4814270A (en) 1984-09-13 1989-03-21 Becton Dickinson And Company Production of loaded vesicles
JPS6176414A (ja) 1984-09-21 1986-04-18 Shionogi & Co Ltd リポソーム製剤の製法
GB8424115D0 (en) 1984-09-24 1984-10-31 Mead Corp Article tray
US5049390A (en) * 1987-09-02 1991-09-17 Allergy Immuno Technologies, Inc. Liposome containing immunotherapy agents for treating IgE mediated allergies
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
US5157207A (en) * 1990-02-06 1992-10-20 Crop Genetics International Modified plant containing a bacterial insculant
GB9018690D0 (en) * 1990-08-24 1990-10-10 Wellcome Found Vaccines
DE4136553A1 (de) * 1991-11-06 1993-05-13 Biotechnolog Forschung Gmbh Impfstoff gegen schleimhauterreger und herstellungsverfahren
EP0684812B1 (de) 1993-02-12 1998-01-21 Mayo Foundation For Medical Education And Research Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren

Also Published As

Publication number Publication date
GB9320668D0 (en) 1993-11-24
BR9407769A (pt) 1997-03-18
CN1108789C (zh) 2003-05-21
EP0722317A1 (de) 1996-07-24
GB2297907A (en) 1996-08-21
GB9607359D0 (en) 1996-07-03
DE69429186T2 (de) 2002-07-11
US6451338B1 (en) 2002-09-17
AU687893B2 (en) 1998-03-05
AU7790794A (en) 1995-05-01
CN1200668A (zh) 1998-12-02
US6322809B1 (en) 2001-11-27
GB2297907B (en) 1997-12-10
NZ274006A (en) 1997-02-24
ES2164714T3 (es) 2002-03-01
US20020041895A1 (en) 2002-04-11
DE69429186D1 (de) 2002-01-03
EP0722317B1 (de) 2001-11-21
JPH09503225A (ja) 1997-03-31
DK0722317T3 (da) 2002-05-21
WO1995009610A1 (en) 1995-04-13
KR100357804B1 (ko) 2004-06-14
RU2145212C1 (ru) 2000-02-10

Similar Documents

Publication Publication Date Title
DE69429186D1 (de) Liposomen, die materialien in partikelform enthalten
HU902472D0 (en) Process for the production of freeze-dryed pharmaceutical products containing active agents
DK74187D0 (da) Praeparat til langsom frigivelse samt fremgangsmaade til fremstilling deraf
DE68904326D1 (de) Physiologisch aktive substanzen enthaltende mikrosphaeren des polymilchsaeuretyps sowie verfahren zu deren herstellung.
ES8707079A1 (es) Un metodo para preparar una composicion de accion prolongada, que contiene un agente biologicamente activo
RU96110886A (ru) Липосомы, содержащие материалы, состоящие из частиц
IT1127216B (it) Metodo per la preparazione di microemulsioni di sostanze organiche,agente tensioattivo per atture il metodo,e microemulsione ottenuta
DE68900900D1 (de) Herstellung von trockenfermenten, die gemische von speziellen arten von lactobacillus und saccharomyces enthalten.
DE59104404D1 (de) Verfahren zur Verkapselung fester oder flüssiger, lipophiler Wirkstoffe zu diesen Wirkstoff enthaltenden Phospholipid-Liposomen sowie Arzneimittel diese Liposomen enthaltend.
CA2173601A1 (en) Liposomes containing particulate materials
RU94041037A (ru) Способ получения препарата на основе стронция-89
FR2600671B1 (fr) Procede de conservation cryogenique de substances et matieres organiques, notamment de cellules
Gehring et al. Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes
RU92015390A (ru) Способ извлечения биологически активных веществ из биомассы микроводоросли рода chlorella
DE3772655D1 (de) Herstellung von methakrylsaeure und katalysatoren dazu.
JPS579711A (en) Preparation of prolonged release type complex
RU17268U1 (ru) Ветеринарный препарат
SU1649807A1 (ru) Способ получения иммобилизованного кардиолипинового антигена для определения специфических антител
DK90184A (da) Fremgangsmaade til fremstilling af let resorberbart ''isoxicam''
Bonzongo et al. Speciation phosphorus techniques in the sediments: Discussion and propositions to evaluate inorganic and organic phosphorus.
Borovec The Bioaccumulation of Metals and Water Re-Treatment Using Bacteria, Fungi and Algae
ATE104847T1 (de) Feste und poroese einzeldosisform, enthaltend perlpartikel und verfahren zu ihrer herstellung.
JPS5612399A (en) Validoxylamine a derivative, its preparation, and agricultural germicide comprising it
Gorunescu et al. Ergodic theorem for a special class of operators.
Bassleer et al. Complementary study of cytotoxic activity of melinonine F.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0722317

Country of ref document: EP

REN Ceased due to non-payment of the annual fee